David Emerson Jorden, Director, 10% Owner at CYTOMEDIX INC (CMXI), bought 17,500 shares at $0.36 ($6K) on 2011-05-04, disclosed to the SEC on 2011-05-04.
Open-market purchase of $6k CMXI by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| AURX | BUY | 2017-08-14 | $54K | — | Filing → |
| PLXP | BUY | 2017-06-16 | $450K | — | Filing → |
| PrivateNuo Therapeutics, Inc. | BUY | 2016-07-29 | $138K | — | Filing → |